Immunotherapy for Melanoma Metastatic to the Brain

Affiliations

¹ From the Renal and Skin Units, Royal Marsden NHS Foundation Trust (S.T., J.L.), and the Translational Cancer Therapeutics Laboratory, Francis Crick Institute (S.T.) - both in London.

Editorial

Samra Turajlic et al. N Engl J Med. 2018.

. 2018 Aug 23;379(8):789-790.

doi: 10.1056/NEJMe1807752.

¹ From the Renal and Skin Units, Royal Marsden NHS Foundation Trust (S.T., J.L.), and the Translational Cancer Therapeutics Laboratory, Francis Crick Institute (S.T.) - both in London.

No abstract available

Comment on

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Tawbi HA, Forsyth PA, Algazi A, Hamid O, Hodi FS, Moschos SJ, Khushalani NI, Lewis K, Lao CD, Postow MA, Atkins MB, Ernstoff MS, Reardon DA, Puzanov I, Kudchadkar RR, Thomas RP, Tarhini A, Pavlick AC, Jiang J, Avila A, Demelo S, Margolin K. Tawbi HA, et al. N Engl J Med. 2018 Aug 23;379(8):722-730. doi: 10.1056/NEJMoa1805453. N Engl J Med. 2018. PMID: 30134131 Free PMC article. Clinical Trial.